The expression levels of p-IKKB, p-IKB, and p-NF-KB (pp65) were then determined by Western blotting, undertaken to investigate the molecular mechanisms of the anti-inflammatory effects on NAFLD. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.